Figure 1From: The applicability of current global cardiovascular risk scores and cardiovascular surrogates in chronic obstructive pulmonary diseaseDifferences in PWV, TAC and their relationship to QRISK2 in COPD compared to controls matched for cardiovascular risk.Back to article page